1. Ohama T. The multiple functions of protein phosphatase 6. Biochim Biophys Acta Mol Cell Res. 2019;1866(1):74-82.
2. Zeng K, Bastos RN, Barr FA, Gruneberg U. Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2. J Cell Biol. 2010;191(7):1315-32.
3. Mi J, Dziegielewski J, Bolesta E, Brautigan DL, Larner JM. Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6. PLoS ONE. 2009;4(2):e4395.
4. Zhong J, Liao J, Liu X, et al. Protein phosphatase PP6 is required for homology-directed repair of DNA double-strand breaks. Cell cycle. 2011;10(9):1411-9.
5. Stefansson B, Brautigan DL. Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IB. J Biol Chem 2006;281(32):22624-34.
6. Kajino T, Ren H, Iemura S, et al. Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. J Biol Chem. 2006;281(52):39891-6.
7. Krauthammer M, Kong Y, Ha BH, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 2012;44(9):1006-14.
8. Bonilla X, Parmentier L, King B, et al. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nat Genet. 2016;48(4):398-406.
9. Yan S, Xu Z, Lou F, et al. NF-B-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat Commun. 2015;6:7652.
10. Wu N, Liu X, Xu X, et al. MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma. FEBS J. 2011;278(12):2044-54.
11. Xianjue Ma, Jin-YL, Yongli D, et al. PP6 Disruption Synergizes with Oncogenic Ras to Promote JNK-Dependent Tumor Growth and Invasion. Cell Rep. 2017;27;19(13):2657-2664.
12. Hayashi K, Momoi Y, Tanuma N, et al. Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA. Oncogene. 2015;34(35):4647-55.
13. Kato H, Kurosawa K, Inoue Y, et al. Loss of protein phosphatase 6 in mouse keratinocytes increases susceptibility to ultraviolet-B-induced carcinogenesis. Cancer Lett. 2015;365(2):223-8.
14. Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269-282.
15. Lawrence MS, Sougnez C, Lichtenstein L, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576-82.
16. Ogoh H, Tanuma N, Matsui Y, et al. The protein phosphatase 6 catalytic subunit (Ppp6c) is indispensable for proper post-implantation embryogenesis. Mech Dev. 2016;139:1-9.
17. Seibler J, Zevnik B, Küter-Luks B, et al. Rapid generation of inducible mouse mutants. Nucleic Acids Res. 2003;15;31(4):e12.
18. Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 2001;15(24):3243-8.
19. Marino S, Vooijs M, Gulden HvD, Jonkers J, Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 2000;14(8):994-1004.
20. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. journal, North America. 2011;9 http://journal.embnet.org/index.php/embnetjournal/article/view/200/479
21. Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011;27(6):863-4.
22. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq Bioinformatics. 2009;25(9):1105-11.
23. Trapnell C, Williams BA, Pertea G, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28(5):511-5.
24. Draghici S, Khatri P, Tarca AL, et al. A systems biology approach for pathway level analysis. Genome Res. 2007;17(10):1537-45.
25. Dang CV, Reddy EP, Shokat KM, Soucek L. Drugging the 'undruggable' cancer targets. Nat Rev Cancer. 2017;17(8):502-508.
26. Patterson KI, Brummer T, O'Brien PM, Daly RJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J. 2009;418(3):475-89.
27. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. 2012;66(2):105-43.
28. Manning BD, Toker A. AKT/PKB Signaling: Navigating the Network. Cell. 2017 Apr 20; 169(3): 381–405.
29. DiDonato JA, Mercurio F, Karin M. NF-B and the link between inflammation and cancer. Immunol Rev. 2012;246(1):379-400.
30. Varfolomeev E, Vucic D. Intracellular regulation of TNF activity in health and disease. Cytokine. 2018;101:26-32.
31. Goradel NH, Najafi M, Salehi E, Farhood B, Mortezaee K. Cyclooxygenase-2 in cancer: A review. J Cell Physiol. 2019;234(5):5683-5699.
32. Fujiwara N, Shibutani S, Sakai Y, et al. Autophagy regulates levels of tumor suppressor enzyme protein phosphatase 6. Cancer Sci. 2020 Sep 24. doi: 10.1111/cas.14662. Online ahead of print.